| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Jasminin; Jasminin | CFN89180 | 30164-93-3 | C26H38O12 = 542.57 | 5mg | QQ客服：215959384 |
| Nudifloside B ; Nudifloside B | CFN89186 | 297740-98-8 | C43H60O22 = 928.92 | 5mg | QQ客服：2056216494 |
| Nudifloside C ; Nudifloside C | CFN89204 | 297740-99-9 | C26H38O12 = 542.57 | 5mg | QQ客服：215959384 |
| Isojasminin; Isojasminin | CFN89205 | 135378-08-4 | C26H38O12 = 542.57 | 5mg | QQ客服：2159513211 |
| 迎春花甙; Jasmoside | CFN89269 | 97763-17-2 | C43H60O22 = 928.92 | 5mg | QQ客服：2159513211 |
| 7-去氧-10-羟基马钱苷元; 7-Deoxy-10-hydroxyloganetin | CFN89296 | 76267-48-6 | C11H16O5 = 228.24 | 5mg | QQ客服：1457312923 |
| Adoxosidic acid; Adoxosidic acid | CFN89313 | 84375-46-2 | C16H24O10 = 376.35 | 10mg | QQ客服：1413575084 |
| 10-O-香豆酰-10-O-去乙酰车叶草苷; 10-O-Coumaroyl-10-O-deacetylasperuloside | CFN89334 | 903519-82-4 | C25H26O12 = 518.47 | 5mg | QQ客服：1413575084 |
| Depressine; Depressine | CFN90972 | 176182-06-2 | C30H40O18 = 688.63 | 5mg | QQ客服：2159513211 |
| 乌奴龙胆苷D; Gentiournoside D | CFN90979 | 157722-21-9 | C23H28O13 = 512.46 | 5mg | QQ客服：1457312923 |
| 木樨榄苷-11-甲酯; Methyloleoside | CFN91892 | 60539-23-3 | C17H24O11 = 404.37 | 5mg | QQ客服：1457312923 |
| 女贞苷G13; GL3 | CFN80115 | 60037-39-0 | C48H64O27 = 1073.02 | 20mg | QQ客服：215959384 |
| 地黄苷C; Rehmannioside C | CFN80135 | 81720-07-2 | C21H34O14 = 510.49 | 5mg | QQ客服：1457312923 |
| 断马钱子酸; Secologanic acid | CFN95028 | 60077-46-5 | C16H22O10 = 374.3 | 20mg | QQ客服：2159513211 |
| Suspenoidside B; Suspenoidside B | CFN95071 | 2161432-08-0 | C25H30O12 = 522.5 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)